U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07633015) titled 'CLINICAL STUDY TO DETERMINE BIOEQUIVALENCE BETWEEN TWO ORAL MEDICATIONS OF EMPAGLIFLOZIN/METFORMIN IN 5 mg / 850 mg TABLETS UNDER FED CONDITIONS.' on June 03.
Brief Summary: Prospective, longitudinal, single-dose, randomized, open-label, crossover 2x2, two treatments, two periods, two sequences controlled clinical study
Study Start Date: Feb. 17, 2025
Study Type: INTERVENTIONAL
Condition:
Bioequivalence Study in Healthy Subjects
Intervention:
DRUG: Test. Empagliflozin/metformin 5/850 mg
Test
DRUG: Synjardy 5/850 mg tablet, Reference
Reference
Recruitment Status: COMPLETED
Sponsor: ADIUM
Published by HT Digital Content Ser...